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Review Article
Poisonings by the toxic alcohols (methanol, ethylene glycol, iso-propanol, diethylene glycol, and propylene glycol) can cause cellular dysfunc-tion and death,1 but symptoms may be nonspecific. Delays in diagnosis in-
crease the risk of irreversible organ damage and death.2 In this review, we discuss 
the mechanisms of toxicity, methods available for diagnosis, and current recom-
mendations for therapy.
Mech a nisms of T ox ici t y
The toxic alcohols are inebriating but are not directly toxic, except for isopropanol. 
Their toxic effects result from their metabolites. A simplified schema depicting 
their primary metabolic pathways is shown in Figure 1A.
Alcohol dehydrogenase catalyzes the first oxidation of the toxic alcohols. The 
resulting aldehydes (except for acetone from isopropanol) undergo further oxida-
tion by aldehyde dehydrogenase to form carboxylic acid metabolites: methanol is 
metabolized to formic acid,3 ethylene glycol to oxalic and glycolic acid,3 diethylene 
glycol to 2-hydroxyethoxyacetic acid and glycolic acid,4 and propylene glycol to 
d-lactic and l-lactic acid.5 Alcohol dehydrogenase is the critical enzyme that 
modulates the production of the toxic metabolites. Coingested ethanol, a competi-
tive substrate for alcohol dehydrogenase, delays production of the toxic metabo-
lites.6 Increased production of lactic acid can result from exposure to the me-
tabolites of methanol or ethylene glycol,3,7 but spurious increments in blood lactate 
may occur with exposure to ethylene glycol metabolites as a result of interference 
of glycolate with the lactate measurement by point-of-care instruments.8
Epidemiol o gic Fe at ur es
The intoxications can occur through different means (Table 1). Methanol intoxication 
most commonly follows ingestion of automotive windshield-washer fluid, indus-
trial products, or adulterated liquids,9 but exposure can also occur through pulmo-
nary and cutaneous routes.10 Ethylene glycol is most commonly ingested by adults 
in antifreeze or in adulterated spirits in which ethylene glycol has been added in 
lieu of ethanol, in an attempt to commit suicide; in children, it is most commonly 
ingested unintentionally. Isopropanol intoxication usually results from ingestion 
of rubbing alcohol, hand sanitizer, and various industrial products, but intoxica-
tion can also be due to inhalation or absorption through dermal or rectal routes.11
Diethylene glycol intoxication results from ingestion of automotive brake fluids 
or industrial products, but it usually occurs in outbreaks in which consumer products 
or oral medications for children contain diethylene glycol in lieu of propylene glycol 
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Figure 1. Metabolic Pathways of Toxic Alcohols and Time Course of Changes in the Osmolal and Anion Gaps 
with and without Coingested Ethanol.
Panel A shows the metabolic pathways of toxic alcohols. Alcohol dehydrogenase and aldehyde dehydrogenase sequen-
tially oxidize the toxic alcohols. Alcohol dehydrogenase catalyzes the first oxidation of the toxic alcohols and is an im-
portant target for antidotal therapy. The enclosed boxes highlight the putative toxic metabolites. Methanol is metabo-
lized to formic acid, ethylene glycol to oxalic and glycolic acid, diethylene glycol to 2-hydroxyethoxyacetic acid and 
glycolic acid, and propylene glycol to D-lactic and L-lactic acid. Panel B shows the time course of changes in the os-
molal and anion gaps with and without coingested ethanol. An increased osmolal gap is prominent early owing to 
the accumulation of the un-ionized alcohols. As metabolism proceeds, the osmolal gap declines with the formation 
of ionized metabolites. Conversely, the serum anion gap is lowest before the alcohol is metabolized and increases 
with the formation of ionized metabolites. The time course of these changes in both parameters varies among the 
alcohols. They typically evolve over several hours to over a day. Coingested ethanol impedes metabolism (dashed 
lines) and delays the onset of the high anion-gap acidosis.
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as a diluent.12,13 In rare cases, dermal absorption 
across nonintact skin may produce toxic ef-
fects.12-14 Propylene glycol is present in numerous 
consumer products and in antifreeze, but intoxi-
cation is usually due to prolonged high-dose 
infusions of medications such as lorazepam that 
contain propylene glycol as a diluent.5,15
Clinic a l Findings
The alcohols initially depress the sensorium and 
later produce organ dysfunction. Methanol is 
associated with decreased vision (in 29 to 72% 
of cases,16 occasionally producing blindness), 
pulmonary dysfunction, abdominal pain, coma, 
and, rarely, Parkinson-like symptoms.17 Clinical 
findings usually evolve over 6 to 24 hours but 
can be delayed as long as 72 to 96 hours if etha-
nol is coingested.18 Neurologic sequelae may 
ensue days or weeks after exposure.19
Ethylene glycol poisoning leads to formation 
of oxalate crystals, which deposit in the lungs, 
heart, and kidney and produce organ dysfunc-
tion.20,21 Cranial nerve damage, sometimes de-
layed for days, can also occur. Neurologic dys-
function develops in the first 12 hours, followed 
by cardiac and pulmonary dysfunction 12 to 
24 hours after exposure and acute kidney injury 
48 to 72 hours after exposure.22 However, the 
organ dysfunction can occur concomitantly. Co-
ingestion of ethanol can delay the appearance of 
clinical abnormalities.20,22
Isopropanol intoxication depresses the sen-
sorium and can produce respiratory dysfunc-
tion, cardiovascular collapse, acute pancreatitis, 
hypotension, and lactic acidosis. Serum isopro-
panol concentrations above 500 mg per decili-
ter (83 mmol per liter) are clinically significant, 
and those greater than 1500 mg per deciliter 
(250 mmol per liter) produce deep coma.23 Ace-
tone can produce a spurious increase in serum 
creatinine concentration as a result of interfer-
ence with laboratory measurement.11
Diethylene glycol poisoning can cause ab-
dominal pain, nausea, vomiting, diarrhea, acute 
pancreatitis, altered mental status, hepatic dis-
ease, central and peripheral neuropathy (some-
times leading to quadriplegia), and acute kidney 
injury.14 Acute kidney injury often appears 8 to 
24 hours after exposure, can require dialysis, 
and is a major cause of death.24,25 Coingestion 
of ethanol can delay toxicity by as long as 48 to 
72 hours.14 Cranial nerve palsies and other neuro-
logic complications can appear 5 days or longer 
after exposure.
Propylene glycol intoxication often produces 
only an increased osmolal gap,22,23 but it can 
produce lactic acidosis and acute kidney injury. 
Preexisting hepatic disease, renal disease, or both 
are predisposing factors. Patients who receive a 
continuous infusion of high-dose lorazepam 
(>10 mg per hour) for more than 48 hours are at 
high risk.
Di agnosis
Information from the medical history, physical 
examination, blood chemical profiles, and tests 
to identify the parent alcohol or its metabolites 
are helpful in diagnosis. History of exposure to 
one of the toxic alcohols is important, given the 
nonspecific clinical findings and the potential 
delay between exposure and their appearance.
Bl o od Chemic a l Profiles
Accumulation of the alcohol increases the serum 
osmolality and the osmolal gap (the difference 
between the serum osmolality measured by the 
freezing-point depression and the serum osmo-
larity estimated from the equation given below). 
Later, accumulation of organic acid anions in-
creases the serum anion gap. The serum osmo-
lality can be estimated with various formulae, 
but the formula that is acceptable for clinical 
purposes is as follows: estimated serum osmo-
lality = (2 × Na+ [in millimoles per liter]) + (blood 
urea nitrogen [in milligrams per deciliter] ÷ 2.8) 
+ (glucose [in milligrams per deciliter] ÷ 18).
The expected normal osmolal gap is 10 to 20 
mOsm per kilogram of water.26 Higher levels re-
flect accumulation of osmotically active substanc-
es such as the toxic alcohols. The increase in the 
serum osmolal gap depends on the serum con-
centration and the molecular weight of the alco-
hols (Table 1).
The basal serum osmolal gap can be less than 
10 mOsm per kilogram of water or even nega-
tive.27 A low basal serum osmolal gap might ob-
scure any increase caused by accumulation of a 
toxic alcohol. A normal osmolal gap cannot be 
used to rule out toxic alcohol ingestion; in one 
study, some patients with toxic alcohol poisonings 
had osmolal gaps within the normal range.28
The New England Journal of Medicine 
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The osmolal gap varies during the course of 
intoxication (Fig. 1B).29,30 Accumulation of the 
parent alcohol initially elevates the osmolal gap, 
but as metabolism progresses, the osmolal gap 
falls. Coingested ethanol (observed in 10 to 60% 
of cases of methanol and ethylene glycol intoxi-
cation)31,32 will contribute to the increase in the 
osmolal gap (increase of 2.17 mOsm per kilo-
gram of water per 10-mg-per-deciliter increase 
in serum alcohol concentration) and will also 
slow metabolism of the alcohols, prolonging the 
duration of an increased osmolal gap.4
The baseline value of the serum anion gap 
(i.e., before the accumulation of organic acid 
anions that results from metabolism of the alco-
hol) can vary by 10 mmol per liter from the low-
est to the highest value.33 If the baseline anion 
gap is low, it might not rise above the upper 
limit of normal despite considerable accumula-
tion of organic acid anions.33,34 Also, the anion 
gap rises as metabolism progresses (Fig. 1B). A 
poisoned patient can present with both a normal 
or high osmolal gap and a normal or elevated 
serum anion gap.20,28,30,35
An elevated osmolal or anion gap does not 
always indicate toxic alcohol poisoning. Lactic 
acidosis, ketoacidosis, chronic kidney disease, 
and the sick cell syndrome all may increase both 
gaps.36 In one study, a minority of the patients 
with increased osmolal and anion gaps had 
toxic alcohol poisoning.28 Some racing fuels con-
taining methanol and nitromethane may falsely 
elevate creatinine concentration as a result of 
interference with laboratory testing by means of 
the Jaffe reaction.37,38
Ethylene glycol is metabolized to oxalic acid, 
which leads to crystalluria and, at times, severe 
acute kidney injury.20,39 Dihydrate crystals appear 
early, and monohydrate crystals appear later. Co-
precipitation of oxalate with calcium can occa-
sionally produce hypocalcemia.20,40 Acetone result-
ing from isopropanol metabolism can produce a 
positive nitroprusside reaction for acetoacetate 
at high concentrations.11 Lactic acidosis due to 
accumulation of the l-isomer is most frequent in 
propylene poisoning, but d-lactic acidosis has 
occurred in some cases.41 Because d-lactic acido-
sis will not be detected by the usual method for 
measuring lactate that detects only the l-isomer, 
the presence of d-lactic acidosis could be missed.
Gas or liquid chromatography most accurately 
detects and quantifies the toxic alcohols in body 
fluids but is laborious, expensive, and often un-
available.42 Table 2 shows other methods to 
identify toxic alcohols that are either in use or in 
development.27,43,46-48,50 Pitfalls in the interpreta-
tion of laboratory data include failure to recognize 
that concentrations may be expressed in milli-
grams per liter or milligrams per deciliter, with 
values higher than 200 mg per liter or 20 mg per 
deciliter indicating the need for treatment. Also, 
tests for volatile substances may detect metha-
nol, ethanol, acetone, and isopropanol but not 
ethylene glycol or diethylene glycol.
Tr e atmen t
Delays in treating toxic alcohol poisonings lead 
to worse outcomes.51 Therefore, therapy should 
commence expeditiously when there is a strong 
suspicion of toxic alcohol poisoning or when 
metabolic acidosis of unknown cause is present.52 
Although there will be variability in the approach 
to diagnosis and treatment of the toxic alcohol 
poisonings, an algorithm consistent with our 
experience and current literature is depicted in 
Figure 2.
Methanol and Ethylene Glycol
Gastrointestinal absorption of methanol or ethyl-
ene glycol is rapid, so gastric decontamination is 
usually not helpful. Treatment includes preven-
tion of metabolism and removal of the alcohol 
and its metabolites from the body.10,51,53-55
Intravenous administration of base solution 
corrects metabolic acidosis and increases the ion-
ization of formate, which facilitates its urinary 
excretion and reduces its penetration into the 
optic nerve.56 Antidotal treatment should com-
mence when the serum methanol or ethylene 
glycol concentration is higher than 20 mg per 
deciliter (methanol, 6 mmol per liter; and ethyl-
ene glycol, 3 mmol per liter) and the patient has 
a documented history of ingesting one of the 
alcohols or when there is strong suspicion that 
the patient ingested one of the alcohols and has 
an osmolal gap greater than 10 mOsm per kilo-
gram of water or metabolic acidosis of unknown 
cause (in accordance with the guidelines from 
the American Academy of Clinical Toxicology 
[AACT]; Table S1 in Supplementary Appendix 1, 
available with the full text of this article at 
NEJM.org). Ethanol has a high affinity for alcohol 
dehydrogenase, and intravenous ethanol, although 
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not approved by the Food and Drug Administra-
tion (FDA), is often used for treatment.57 A serum 
ethanol concentration of 100 mg per deciliter 
(22 mmol per liter) provides competitive inhibi-
tion of the enzyme. Advantages include its ready 
availability and low cost. Disadvantages include 
the need for compounding by a pharmacist for 
intravenous use, the need for frequent monitor-
ing of serum concentrations, its effect in blunting 
the sensorium, and the need for hospitalization 
in the intensive care unit.
Fomepizole (or 4-methylpyrazole) is a strong 
inhibitor of alcohol dehydrogenase (fomepizole 
has an affinity for alcohol dehydrogenase 8000 
times that of ethanol) that received FDA approval 
for the treatment of ethylene glycol and methanol 
poisoning in 1997 and 2000, respectively,52 but it 
is not approved for the treatment of the other 
toxic alcohol poisonings. Fomepizole is effective 
at low concentrations, has minimal side effects, 
and does not require monitoring in an intensive 
care unit.58,59 For patients who are not undergo-
ing dialysis, the loading dose is 15 mg per kilo-
gram of body weight, followed by a maintenance 
dose of 10 mg per kilogram every 12 hours.52 
Because fomepizole may induce its own metabo-
lism by cytochrome P-450 enzymes, after 48 hours 
the maintenance dose is increased to 15 mg per 
kilogram every 12 hours. The drug may be re-
moved by dialysis, and therefore giving it imme-
diately after dialysis is recommended. The package 
insert gives a more detailed schedule for patients 
who receive treatment with both fomepizole and 
hemodialysis (see Supplementary Appendix 1).60
In the United States, fomepizole is frequently 
used to treat methanol and ethylene glycol poi-
sonings. In 2012 and 2015, fomepizole was used 
in 90 to 94% of cases, and ethanol was used in 
5 to 6% of cases.61 Outside the United States, 
fomepizole is less readily available and ethanol is 
used more frequently.55,62,63 Oral ethanol is effec-
tive when intravenous ethanol is not available.64 
In 2013, the World Health Organization added 
fomepizole to the list of essential medications.65
A systematic review of the literature from 
1974 through August 2010 showed that mortal-
ity among patients who ingested methanol or 
ethylene glycol and received treatment with 
ethanol was 21.8% and 18.1%, respectively.59 
Mortality among patients who ingested metha-
nol or ethylene glycol and received treatment 
with fomepizole was 17.1% and 4.1%, respec-
tively. Adverse events occurred more frequently 
with ethanol than with fomepizole (57% vs. 
Test Comment
Wood’s lamp to detect urine fluores-
cence
Detects fluorescein in antifreeze (ethylene glycol); false positives and false nega-
tives occur frequently, which makes the test unreliable43
Alco-Screen (AlcoPro), a reagent 
strip containing alcohol oxidase
Ethanol and methanol are detected at low serum concentrations (5 mg/dl), but 
ethylene glycol is detected only at high concentrations (>300 mg/dl)44
Portable dry strip with enzyme for-
mate dehydrogenase and forma-
zan dye
Useful in the diagnosis of methanol poisoning45; serum methanol concentration 
is indirectly determined from assessment of serum formate concentration; 
positive results are detected by visual inspection and by means of a photome-
ter
Modified rapid veterinary assay for 
the detection of ethylene glycol 
(Catachem)
An ethylene glycol assay that has been modified for use with automated clinical 
analyzers; good correlation with ethylene glycol concentrations measured by 
means of gas chromatography; also detects propylene glycol, so it could be 
used in suspected cases of this poisoning46,47
Liquid-based tests that use the en-
zymes alcohol oxidase or alcohol 
dehydrogenase or the oxidizing 
agents sodium periodate or po-
tassium permanganate to detect 
toxic alcohols in saliva
Tests performed with the use of saliva that has been spiked with various toxic al-
cohols; detects concentrations of alcohols as low as 5 mg per deciliter48; re-
quires confirmation of accuracy with the saliva from actual patients
Gas or liquid chromatography with 
flame-ionization detection
Most precise method to detect toxic alcohols; laborious and expensive; not avail-
able in most clinical laboratories49
*  To convert the values for ethanol, methanol, and ethylene glycol to millimoles per liter, multiply by 0.2171 for ethanol, 
by 0.3121 for methanol, and by 0.1611 for ethylene glycol.
Table 2. Diagnostic Tests for the Detection of Toxic Alcohols.*
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Figure 2. Algorithm for the Diagnosis and Treatment of Methanol, Ethylene Glycol, and Isopropanol Intoxications.
This algorithm provides an approach to the diagnosis and treatment of the three most common poisonings. A similar approach might be use-
ful for diethylene glycol poisoning, although this poisoning is rare. One criterion for dialysis (serum ethylene glycol concentration, >300 mg 
per deciliter after antidote administration) reflects the practice of the second author. To convert the values for methanol, ethylene glycol, 
and isopropanol to millimoles per liter, multiply by 0.3121 for methanol, by 0.1611 for ethylene glycol, and by 0.1664 for isopropanol.
Potential ingestion of ethylene glycol,
methanol, or isopropanol
Most likely alcohol poisoning
Is there an indication for dialysis?
Any one of the following:
pH <7.3
Serum methanol concentration >50 mg/dl
Serum ethylene glycol concentration >50 mg/dl
(no antidote given)
Serum ethylene glycol concentration >300 mg/dl
(after antidote administration)
Serum isopropanol concentration >500 mg/dl
Acute kidney injury
Discontinue treatment
Repeat laboratory testing
Reassess clinical status
Continue antidote
administration
Is there an indication for an antidote?
Either of the following:
Serum ethylene glycol concentration ≥20 mg/dl
Serum methanol concentration ≥20 mg/dl
Perform dialysis
Readminister fomepizole after dialysis
Is there a high-risk finding?
Any one of the following:
History of exposure (e.g., antifreeze, windshield-washer
fluid, adulterated alcohol, hand sanitizer, rubbing
alcohol)
Increased osmolal gap
Increased anion gap
Blurred vision (indicates methanol poisoning)
Acute kidney injury (indicates ethylene glycol poisoning)
Oxalate crystalluria (indicates ethylene glycol poisoning)
Acetonemia (indicates isopropanol poisoning)
Measure serum ethylene glycol, methanol, isopropanol, and
acetone concentrations
Consult nephrology or toxicology service, or regional poison
control center (800-222-1222 in the United States)
Intravenous fluid
resuscitation
Antidote not required
for isopropanol
Give loading dose of antidote while awaiting serum
ethylene glycol and methanol results: fomepizole
(preferred) or ethanol (alternative) 
Consider alternative
diagnoses (e.g., sepsis, lactic
acidosis, ketoacidosis, trauma)
Obtain screening laboratory tests: electrolytes, blood urea
nitrogen, creatinine, glucose, venous or arterial blood gases,
 lactate, serum ethanol, serum osmolality, and urinalysis
Yes
Ethylene glycol or methanol
No
No Yes
Yes
No
Isopropanol
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12%).66 The cost of fomepizole was often given 
as a reason to forgo its use. However, the in-
troduction of generic forms has reduced the 
cost considerably.58 Thus, fomepizole is preferable 
for treatment of these poisonings, but ethanol is 
effective when fomepizole is not available.63,67
The toxic alcohols and their metabolites are 
small and water soluble and are removed during 
hemodialysis. Guidelines for the use of hemodi-
alysis in the treatment of methanol51 or ethylene 
glycol53 intoxication from the AACT and for treat-
ment of methanol poisoning from the Extra-
corporeal Treatments in Poisoning Workgroup 
(EXTRIP)35 are provided in Table S1 in Supple-
mentary Appendix 1. In general, both guidelines 
recommend dialysis with severe metabolic acido-
sis, serum methanol and ethylene glycol concen-
trations higher than 50 mg per deciliter (metha-
nol, 16 mmol per liter; ethylene glycol, 8 mmol 
per liter), deteriorating vital signs despite sup-
portive care, and problems with vision (associated 
with methanol poisoning) or acute kidney injury. 
Intermittent hemodialysis (with a large-surface-
area dialyzer and high-flux membrane) removes 
toxic alcohols more rapidly than continuous re-
nal replacement therapy.35,68,69
Treatment of methanol or ethylene glycol in-
toxication with fomepizole alone (without hemo-
dialysis) with no adverse consequences has been 
reported.31,70-72 However, fomepizole prolongs the 
elimination half-lives of methanol and ethylene 
glycol to as high as 71 hours31 and 16 hours,58 
respectively, as compared with 2.5 and 2.7 hours, 
respectively, with dialysis. A longer duration of 
exposure increases days of hospitalization and 
cost — reasons that are given by some experts 
to support the inclusion of hemodialysis.73 The 
comparative costs of the two treatments will 
depend on several factors, including exposure 
dose, relative costs of the drug, cost of dialysis, 
and room costs, and should be factored in the 
decision about therapy.74
Treatment in children is similar to that in 
adults.75 Further examination of the value and 
limitations of hemodialysis with or without an 
alcohol dehydrogenase inhibitor in the treatment 
of these intoxications is warranted. An interactive 
program to predict the duration of dialysis re-
quired to lead to reductions in the parent alcohol 
and metabolites to safe levels is shown in Sup-
plementary Appendix 2, available at NEJM.org.76 
Body redistribution of the alcohol, metabolites, 
or both might require repeat dialysis.
In methanol poisoning, 1 mg per kilogram of 
folic acid every 4 to 6 hours promotes the con-
version of formic acid to carbon dioxide and 
water. In ethylene glycol poisoning, pyridoxine 
and thiamine promote the metabolism of glycolic 
acid to less toxic compounds.56
Diethylene Glycol
Several experts recommend the use of alcohol 
dehydrogenase inhibitors in the treatment of 
diethylene glycol poisoning.58,72 Fomepizole alone 
has been successful,77 but because acute kidney 
injury is common, it seems reasonable to treat 
patients with both fomepizole and hemodi-
alysis.78
Isopropanol
Supportive measures are often sufficient, but he-
modialysis may be necessary if the serum iso-
propanol concentration is 500 mg per deciliter 
(83 mmol per liter) or more or if hypotension or 
lactic acidosis is present.11 Alcohol dehydroge-
nase inhibitors slow the removal of isopropanol 
and should not be used.23
Propylene Glycol
In most cases, the elevated serum osmolality re-
solves with discontinuation of the drug contain-
ing propylene glycol.5 There is no consensus re-
garding the use of fomepizole, but if lactic 
acidosis develops, hemodialysis has been recom-
mended.5,79
Moni t or ing of Patien t s
Patients with severe poisoning or hemodynamic 
instability or those who are receiving ethanol 
therapy warrant care in an intensive care unit, 
but patients with less severe poisoning or hemo-
dynamic stability or those who are receiving 
fomepizole therapy can safely be cared for outside 
the intensive care unit. Measurements of acid–
base variables, electrolytes, renal function, and 
serum osmolality are necessary to assess the re-
sponse to therapy. Measurement of serum con-
centrations of the toxic alcohols would be ideal 
to monitor treatment; however, obtaining serum 
concentrations in a timely fashion is not often 
feasible. In their absence, the serum concentra-
tion of the toxic alcohol can be estimated from 
the osmolal gap.16,80 Therapy should continue 
until the serum concentration of ethylene glycol 
or methanol falls below 20 to 30 mg per deciliter 
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(ethylene glycol, 3 to 5 mmol per liter; methanol, 
6 to 9 mmol per liter).21,35
Conclusions a nd Fu t ur e 
Dir ec tions
Methanol, ethylene glycol, and diethylene glycol 
poisoning can cause severe cellular dysfunction 
and high mortality if not recognized and treated 
quickly. Isopropanol frequently causes medical 
complications but has a lower risk of death. A 
high anion-gap metabolic acidosis, an increased 
serum osmolal gap, or both can suggest that one 
of the toxic alcohols is present in the blood, but 
these abnormal laboratory results are not always 
present. One of the poisonings should be strong-
ly suspected in persons with the clinical findings 
described previously, in all obtunded patients, or 
in those with an unexplained high osmolal gap, 
high anion-gap metabolic acidosis, or both. De-
finitive tests such as high-pressure liquid chroma-
tography are not always available, even in devel-
oped countries but especially in undeveloped 
countries. Therefore, there is an unmet need for 
tests that are accurate and can be completed 
rapidly.
Treatment with alcohol dehydrogenase inhibi-
tors and the use of dialysis are effective, but both 
methods are not always available. Also, there is 
no consensus on when one or both methods 
should be used. Despite much progress in our 
understanding of the pathogenesis of reactions 
to these toxic alcohols and despite the develop-
ment of effective treatments, much remains to 
be done to eliminate the severe clinical distur-
bances that result from exposure to these sub-
stances.
No potential conflict of interest relevant to this article was 
reported.
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
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